X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Clinical Trials News - 27/Aug 23:08

Lilly Releases Zepbound (tirzepatide) Single-Dose Vials, Expanding Supply and Access for Adults Living with Obesity

INDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound® (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly...

Articles similaires

Sorry! Image not available at this time

In a First-of-its-kind Fixed Dose Study, Once Weekly Insulin Efsitora Alfa Leads to A1C Reduction Similar to Daily Insulin

drugs.com - 05/Sep 06:09

INDIANAPOLIS, Sept. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-1 and QWINT-3...

Sorry! Image not available at this time

In a First-of-its-kind Fixed Dose Study, Once Weekly Insulin Efsitora Alfa Leads to A1C Reduction Similar to Daily Insulin

drugs.com - 05/Sep 06:09

INDIANAPOLIS, Sept. 5, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced positive topline results from the QWINT-1 and QWINT-3...

Sorry! Image not available at this time

Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes

drugs.com - 10/Sep 15:09

INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...

Sorry! Image not available at this time

Once-weekly dose of insulin efsitora alfa delivers A1C reduction consistent with the most advanced daily insulin in people with type 2 diabetes

drugs.com - 10/Sep 15:09

INDIANAPOLIS, Sept. 10, 2024. Eli Lilly and Company today announced detailed results from the QWINT-2 phase 3 trial evaluating once-weekly insulin...

Sorry! Image not available at this time

Bull of the Day: Eli Lilly (LLY)

zacks.com - 12/Sep 08:30

Eli Lilly stock boasts both defensive and growth characteristics

Sorry! Image not available at this time

Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?

zacks.com - 04/Sep 16:00

Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Sorry! Image not available at this time

Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?

zacks.com - 04/Sep 16:00

Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Sorry! Image not available at this time

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

zacks.com - 06/Sep 13:00

Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.

Sorry! Image not available at this time

Low-Dose Triple-Pill Protocol Lowers BP in Black Africans With Hypertension

drugs.com - 10/Sep 16:09

TUESDAY, Sept. 10, 2024 -- For Black African adults with uncontrolled hypertension, a low-dose triple-pill protocol achieves better blood pressure...

Sorry! Image not available at this time

NVO Oral Obesity Pill Tops Wegovy; LLY, VKTX, GPCR Stocks Rise

zacks.com - 12/Sep 19:00

Stocks of LLY, VKTX and GPCR, which make oral pills for obesity, rose on Wednesday in response to Novo Nordisk's positive data.

Les derniers communiqués